These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 7651928)
1. Estrogen and progesterone receptor content in bilateral breast cancer. Branković-Magić M; Nikolić-Vukosavljević D; Nesković-Konstantinović Z; Kanjer K; Spuzić I Pathol Res Pract; 1995 Feb; 191(1):16-24. PubMed ID: 7651928 [TBL] [Abstract][Full Text] [Related]
2. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788 [TBL] [Abstract][Full Text] [Related]
3. [Androgen receptors in primary breast carcinoma. Relation to prognostic factors in comparison with estrogen and progesterone receptors]. Reiner G; Jakesz R; Kolb R; Kühnl-Brady K; Reiner A; Schemper M; Spona J Dtsch Med Wochenschr; 1988 Jun; 113(22):892-7. PubMed ID: 3371221 [TBL] [Abstract][Full Text] [Related]
4. Estrogen and progesterone receptor status of primary breast cancer: relationship with the pattern of first metastasis and survival. Bhatavdekar JM; Patel DD; Karelia NH; Trivedi SN; Shah NG; Vora HH; Ghosh N; Balar DB Neoplasma; 1992; 39(6):349-52. PubMed ID: 1491724 [TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis. Berger U; McClelland RA; Wilson P; Greene GL; Haussler MR; Pike JW; Colston K; Easton D; Coombes RC Cancer Res; 1991 Jan; 51(1):239-44. PubMed ID: 1846309 [TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors]. Ellinidi VN; Anikseeva NV; Goncharova OA; Krasnozhon DA; Fedorov KA Vopr Onkol; 2004; 50(2):234-6. PubMed ID: 15176229 [TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor status of breast cancer metastases. Branković-Magić M; Janković R; Nesković-Konstantinović Z; Nikolić-Vukosavljević D J Cancer Res Clin Oncol; 2002 Jan; 128(1):55-60. PubMed ID: 11862473 [TBL] [Abstract][Full Text] [Related]
9. Estrogen dependence of primary breast cancer--correlation with histologic type and grade. Nikolić-Vukosavljević D; Branković-Magić M; Polić D; Vlajić M; Vuletić L; Spuzić I Neoplasma; 1992; 39(5):299-304. PubMed ID: 1436244 [TBL] [Abstract][Full Text] [Related]
10. Bilateral breast cancer. Gogas J; Markopoulos C; Skandalakis P; Gogas H Am Surg; 1993 Nov; 59(11):733-5. PubMed ID: 8239195 [TBL] [Abstract][Full Text] [Related]
11. Bilateral breast cancer: differential diagnosis using histological and biological parameters. Gong SJ; Rha SY; Jeung HC; Roh JK; Yang WI; Chung HC Jpn J Clin Oncol; 2007 Jul; 37(7):487-92. PubMed ID: 17673471 [TBL] [Abstract][Full Text] [Related]
12. [Cancer of the breast and the receptor status]. Buonomo O; Serao A; Muggianu A; Guglielmelli E; Davoli E; Amori A G Chir; 1991 Apr; 12(4):274-7. PubMed ID: 1911078 [TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical comparison between GCDFP-15 and estrogen and progesterone receptors in the diagnosis of metastatic carcinoma of the breast]. Villarroel Salinas J; Ortiz Hidalgo C; Soria Céspedes D Gac Med Mex; 2012; 148(3):213-7. PubMed ID: 22820353 [TBL] [Abstract][Full Text] [Related]
14. [Influence of steroid receptors content in primary breast cancer on early relapse pattern]. Vuletić L; Nesković-Konstantinović Z; Nikolić D; Vuković Dj; Vlajić M; Spuzić I Srp Arh Celok Lek; 1994; 122(7-8):200-3. PubMed ID: 17974385 [TBL] [Abstract][Full Text] [Related]
15. Correlation of steroid receptors in synchronous tissues with survival in breast cancer patients. Bhatavdekar JM; Patel DD; Karelia NH; Suthar TP; Shah NG; Vora HH; Ghosh N; Nadkarni SP; Balar DB Neoplasma; 1993; 40(3):177-80. PubMed ID: 8350965 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information. Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer. Kurebayashi J; Ishida T; Higashi Y; Suemasu K; Nomoto C; Yoshida K Jpn J Clin Oncol; 1990 Sep; 20(3):271-80. PubMed ID: 2255103 [TBL] [Abstract][Full Text] [Related]
18. [The significance of hormone receptor content in primary tumors for cytostatic therapy of advanced breast carcinoma]. Petru E; Beck K; Schünemann H; Schmähl D Wien Med Wochenschr; 1991; 141(7):133-5. PubMed ID: 2058160 [TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients. Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582 [TBL] [Abstract][Full Text] [Related]
20. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue]. Schulze MH; Buchmann J Zentralbl Gynakol; 2000; 122(2):92-5. PubMed ID: 10721188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]